1. Home
  2. CYTK vs IDA Comparison

CYTK vs IDA Comparison

Compare CYTK & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • IDA
  • Stock Information
  • Founded
  • CYTK 1997
  • IDA 1915
  • Country
  • CYTK United States
  • IDA United States
  • Employees
  • CYTK N/A
  • IDA N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • IDA Electric Utilities: Central
  • Sector
  • CYTK Health Care
  • IDA Utilities
  • Exchange
  • CYTK Nasdaq
  • IDA Nasdaq
  • Market Cap
  • CYTK 5.6B
  • IDA 6.1B
  • IPO Year
  • CYTK 2004
  • IDA N/A
  • Fundamental
  • Price
  • CYTK $44.53
  • IDA $112.75
  • Analyst Decision
  • CYTK Strong Buy
  • IDA Buy
  • Analyst Count
  • CYTK 17
  • IDA 6
  • Target Price
  • CYTK $82.00
  • IDA $120.50
  • AVG Volume (30 Days)
  • CYTK 1.6M
  • IDA 324.9K
  • Earning Date
  • CYTK 05-07-2025
  • IDA 05-01-2025
  • Dividend Yield
  • CYTK N/A
  • IDA 3.07%
  • EPS Growth
  • CYTK N/A
  • IDA 7.00
  • EPS
  • CYTK N/A
  • IDA 5.50
  • Revenue
  • CYTK $18,474,000.00
  • IDA $1,826,633,000.00
  • Revenue This Year
  • CYTK $176.28
  • IDA $8.34
  • Revenue Next Year
  • CYTK $361.83
  • IDA $7.28
  • P/E Ratio
  • CYTK N/A
  • IDA $20.35
  • Revenue Growth
  • CYTK 145.34
  • IDA 3.41
  • 52 Week Low
  • CYTK $40.53
  • IDA $88.70
  • 52 Week High
  • CYTK $75.71
  • IDA $120.42
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 50.85
  • IDA 46.18
  • Support Level
  • CYTK $42.66
  • IDA $113.62
  • Resistance Level
  • CYTK $48.43
  • IDA $117.31
  • Average True Range (ATR)
  • CYTK 2.09
  • IDA 1.77
  • MACD
  • CYTK 0.28
  • IDA -0.35
  • Stochastic Oscillator
  • CYTK 51.02
  • IDA 31.30

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About IDA IDACORP Inc.

Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.

Share on Social Networks: